AIMTo evaluate the effectiveness of human fibrinogen-thrombin collagen patch (TachoSil<sup>®</sup>) in the reinforcement of high-risk colon anastomoses.METHODSA quasi-experimental study was con...AIMTo evaluate the effectiveness of human fibrinogen-thrombin collagen patch (TachoSil<sup>®</sup>) in the reinforcement of high-risk colon anastomoses.METHODSA quasi-experimental study was conducted in Wistar rats (n = 56) that all underwent high-risk anastomoses (anastomosis with only two sutures) after colectomies. The rats were divided into two randomized groups: Control group (24 rats) and treatment group (24 rats). In the treatment group, high-risk anastomosis was reinforced with TachoSil<sup>®</sup> (a piece of TachoSil<sup>®</sup> was applied over this high-risk anastomosis, covering the gap). Leak incidence, overall survival, intra-abdominal adhesions, and histologic healing of anastomoses were analyzed. Survivors were divided into two subgroups and euthanized at 15 and 30 d after intervention in order to analyze the adhesions and histologic changes.RESULTSOverall survival was 71.4% and 57.14% in the TachoSil<sup>®</sup> group and control group, respectively (P = 0.29); four rats died from other causes and six rats in the treatment group and 10 in the control group experienced colonic leakage (P > 0.05). The intra-abdominal adhesion score was similar in both groups, with no differences between subgroups. We found non-significant differences in the healing process according to the histologic score used in both groups (P = 0.066).CONCLUSIONIn our study, the use of TachoSil<sup>®</sup> was associated with a non-statistically significant reduction in the rate of leakage in high-risk anastomoses. TachoSil<sup>®</sup> has been shown to be a safe product because it does not affect the histologic healing process or increase intra-abdominal adhesions.展开更多
文摘AIMTo evaluate the effectiveness of human fibrinogen-thrombin collagen patch (TachoSil<sup>®</sup>) in the reinforcement of high-risk colon anastomoses.METHODSA quasi-experimental study was conducted in Wistar rats (n = 56) that all underwent high-risk anastomoses (anastomosis with only two sutures) after colectomies. The rats were divided into two randomized groups: Control group (24 rats) and treatment group (24 rats). In the treatment group, high-risk anastomosis was reinforced with TachoSil<sup>®</sup> (a piece of TachoSil<sup>®</sup> was applied over this high-risk anastomosis, covering the gap). Leak incidence, overall survival, intra-abdominal adhesions, and histologic healing of anastomoses were analyzed. Survivors were divided into two subgroups and euthanized at 15 and 30 d after intervention in order to analyze the adhesions and histologic changes.RESULTSOverall survival was 71.4% and 57.14% in the TachoSil<sup>®</sup> group and control group, respectively (P = 0.29); four rats died from other causes and six rats in the treatment group and 10 in the control group experienced colonic leakage (P > 0.05). The intra-abdominal adhesion score was similar in both groups, with no differences between subgroups. We found non-significant differences in the healing process according to the histologic score used in both groups (P = 0.066).CONCLUSIONIn our study, the use of TachoSil<sup>®</sup> was associated with a non-statistically significant reduction in the rate of leakage in high-risk anastomoses. TachoSil<sup>®</sup> has been shown to be a safe product because it does not affect the histologic healing process or increase intra-abdominal adhesions.
